Next Article in Journal
Low Post-Treatment Quality of Life and the High Incidence of Pain Are Common and Significantly Exacerbated in Depressed Head and Neck Patients Treated with Definitive Accelerated Radiotherapy
Next Article in Special Issue
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial
Previous Article in Journal
The Role of tRNA-Centered Translational Regulatory Mechanisms in Cancer
Previous Article in Special Issue
Pediatric Acute Myeloid Leukemia Post Cytotoxic Therapy—Retrospective Analysis of the Patients Treated in Poland from 2005 to 2022
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 1
10.3390/cancers16010078
Review Report
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia

Cancers 2024, 16(1), 78; https://doi.org/10.3390/cancers16010078
by Valeria Ceolin 1,2,†, Sae Ishimaru 1,†, Seth E. Karol 3, Francisco Bautista 1,4, Bianca Frederika Goemans 1, Gwenaëlle Gueguen 5, Marieke Willemse 1, Laura Di Laurenzio 6, Jennifer Lukin 6, Harm van Tinteren 1, Franco Locatelli 7, Arnaud Petit 8, Daisuke Tomizawa 9, Alice Norton 10, Gertjan Kaspers 1,11, Dirk Reinhardt 12, Sarah K. Tasian 13, Gwen Nichols 6, Edward Anders Kolb 6, Christian Michel Zwaan 1,4,14,*,‡ and Todd Michael Cooper 15,‡add Show full author list remove Hide full author list
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2024, 16(1), 78; https://doi.org/10.3390/cancers16010078
Submission received: 20 November 2023 / Revised: 14 December 2023 / Accepted: 15 December 2023 / Published: 22 December 2023
(This article belongs to the Special Issue New Perspectives on Acute Myeloid Leukemia in Children)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

In their manuscript “The PedAL/EuPAL project: a global initiative to address the unmet medical needs of pediatric patients with relapsed or refractory acute myeloid leukemia”, the authors describe a global-scale project aiming to establish sufficient cohorts of pediatric patients with relapsed or refractory acute myeloid leukemia (AML). The goal is to offer therapeutic alternatives based on biology and genetic markers and to facilitate access to new therapies developed for adult AML in pediatric cases.

The manuscript is descriptive and does not present original data. It is a literature review followed by a perspective on future developments. The tables and figures provide a good overview. The perspectives focus heavily on therapies targeting genetic alterations or antigens. The authors discuss little about strategies considering measurable residual disease kinetics and possibly managing molecular relapses or persistent MRD. I have no further comments on the content.

Author Response

Thank you for your comment.

My best regards, 

Valeria Ceolin

Reviewer 2 Report

Comments and Suggestions for Authors

A very interesting and well-prepared manuscript, describes the history of AML  therapy, current methods used in Europe and around the world, and new directions in therapy, especially targeted treatment. I have no comments on the presented manuscript.

Author Response

Thank you.

My best regards, 

Valeria Ceolin

Back to TopTop